Su et al.
After removal of the solvent, the residue was diluted by a
solution of THF (4 mL), CH3OH (4 mL) and aq NaOH (6.0 M,
2 mL). The resultant mixture was stirred at 60 °C for 6 h and then
was cooled to room temperature. It was extracted with CH2Cl2 (3ꢀ
10 mL) and the combined organic layers were washed with brine
and dried over Na2SO4. After the solid was filtered off, the filtrate
was immediately treated with saturated solution of HCl in MeOH
(6 mL) at 0 °C for 30 min. Then, the solvent was removed in
vacuum and the residue was recrystallized from MeOH-Et2O to
JOCArticle
5H), 1.37-1.25 (m, 1H). 13C NMR: δ 149.8, 149.1, 140.7, 115.9,
66.2, 66.0, 51.9, 51.7, 51.5, 51.2, 32.8, 25.8, 25.2, 23.5, 21.4. MS m/z
(%): 182 (Mþ, 0.42), 124 (100). Anal. calcd for C10H18N2O: C,
65.90; H, 9.95; N, 15.37; Found: C, 65.95; H, 9.92; N, 15.26.
By similar procedure, 4-methyl-benzenesulfonamides 12b-12k
were converted into 13b-13k (see Supporting Information).
Preparation of (10aR,9bR)-Octahydro-1H-isoxazolo[4,3-a]qui-
nolizine (14a), A Typical Procedure of INOC. To a stirred solution
of compound 13a (91 mg, 0.5 mmol) in CH2Cl2 (5 mL) was added
an aqueous solution of NaOCl (10%, 0.9 mL) at 0 °C within 30 min.
Then the reaction was stirred at room temperature for 2 h (moni-
tored by TLC). After the reaction was quenched by H2O (20 mL),
the resultant mixture was extracted by CH2Cl2 (2 ꢀ 20 mL). The
combined organic layers were washed with brine (20 mL) and dried
over Na2SO4. Removal of the solvent gave a residue, which was
purified by chromatography (silica gel, 50% EtOAc in PE) to give
79 mg (88%) of product 14a as a yellowish oil, [R]D20 =-30.4 (c 0.9,
CHCl3). IR: v 2929, 2856, 2800, 2763 cm-1. 1H NMR: δ 4.50-4.43
(m, 1H), 3.83-3.77 (m, 1H), 3.08-2.93 (m, 3H), 2.76-2.70 (m,
1H), 2.55-2.45 (m, 1H), 2.20-2.03 (m, 2H), 1.80-1.54 (m, 5H),
1.38-1.16 (m, 2H). 13C NMR: δ 157.7, 70.5, 67.3, 55.2, 55.1, 54.0,
32.3, 25.2, 24.7, 23.4. MS m/z(%):180(Mþ, 42.12), 179 (100). Anal.
calcd for C10H16N2O: C, 66.63; H, 8.95; N, 15.54. Found: C, 66.81;
H, 8.89; N, 15.42.
give product (R)-5 HCl as a white crystal (410 mg, 93%). It had mp
199-200 °C (MeOH-Et2O). [R]D20 = þ5.5 (c 0.2, CHCl3); IR: v
3
1
3440, 2983, 1252, 1013 cm-1. H NMR: δ 9.53-9.40 (m, 2H),
6.13-6.02 (m, 1H), 5.56-5.37 (m, 2H), 3.60-3.43 (m, 2H),
2.95-2.88 (m, 1H), 2.04-1.82 (m, 5H), 1.55-1.52 (m, 1H). 13C
NMR: δ 133.3, 120.5, 58.1, 44.2, 28.1, 21.8, 21.5. MS m/z (%): 111
(Mþ - HCl, 1.71), 84(100). Anal. calcdforC7H14ClN: C, 56.94; H,
9.56; N, 9.49. Found: C, 56.67; H, 9.43; N, 9.66.
Preparation of (R)-3-(2-Vinylpiperidin-1-yl)propan-1-ol (11a).
The mixture of compound (R)-5 HCl (2.00 g, 13.5 mmol),
3
ClCH2CH2CH2OH (1.42 g, 15 mmol), dry K2CO3 (4.14 g, 30
mmol) and KI (2.49 g, 15 mmol) in acetone (50 mL) was refluxed
for 2 h. Then the solid was filtrated off and the solvent was
evaporated. The residue was purified by chromatography (silica
gel, EtOAc) to give 2.18 g (95%) of product 11a as a colorless oil,
20
By similar procedure, 3-aminopropanal oximes 13b-13d
were converted into 14b-14d (see Supporting Information).
(1S,9aR)-Octahydro-1-hydroxymethyl-2H-quinolizin-2-one (15).
At room temperature, a suspension of compound 14a (400 mg,
2.22 mmol), Raney nickel (13 mg, 0.22 mmol) and HOAc (1.33 g,
22.2 mmol) in aqueous MeOH (75%, 20 mL) under H2 (balloon)
was vigorously stirred for 1.5 h. Then the reaction was quenched by
saturated aqueous Na2CO3 (20 mL) and the catalyst was filtrated
off. The filtration was extracted with EtOAc (3 ꢀ 20 mL) and
combined organic layers were washed with brine (20 mL) and dried
over Na2SO4. Removal of the solvent gave a residue, which was
purified by chromatography (silica gel, EtOAc) to give 342 mg
(84%) of product 15 as a white solid. It had mp 69-71 °C (EtOAc),
[R]D20 =þ8.8 (c 0.04, CHCl3). IR:v3440, 1714, 1092, 647 cm-1. 1H
NMR: δ 3.97-3.93 (m, 1H), 3.74-3.68 (m, 1H), 3.14-3.05 (m,
1H), 3.00-2.96 (m, 1H), 2.83-2.70 (m, 2H), 2.46-2.33 (m, 3H),
2.17-2.07 (m, 2H), 1.98-1.95 (m, 1H), 1.83-1.56 (m, 3H),
1.40-1.20 (m, 2H). 13C NMR: δ 211.9, 63.0, 58.3, 56.6, 55.69,
55.67, 41.7, 31.1, 25.3, 23.3. MS m/z (%): 183 (Mþ, 28.76), 28 (100).
Anal. calcd for C10H17NO2: C, 65.54; H, 9.35; N, 7.64. Found: C,
65.81; H, 9.42; N, 7.56.
[R]D = þ76.4 (c 0.2, CHCl3). IR: v 3387, 2933, 2857, 1053
cm-1. 1H NMR: δ 5.78-5.67 (m, 1H), 5.49 (s, 1H), 5.10-4.99
(m, 2H), 3.70-3.63 (m, 2H), 3.10-2.87 (m, 2H), 2.53-2.48 (m,
1H), 2.23-2.14 (m, 1H), 1.86-1.25 (m, 9H). 13C NMR: δ 141.0,
116.0, 66.9, 64.2, 54.9, 51.7, 33.5, 27.1, 25.5, 23.3. MS m/z (%):
169 (Mþ, 1.87), 124 (100). Anal. calcd for C10H19NO: C, 70.96;
H, 11.31; N, 8.28. Found: C, 71.21; H, 11.24; N, 8.32.
Preparation of N-[(2R)-2-Vinyl-1-piperidine-propyl]-N-[(tert-
butyl-dimethylsilyl)oxy]-4-methyl-benzenesulfonamide (12a), a
Typical Procedure of Mutsunobu Reaction. To a stirred solution
of 11a (508 mg, 3 mmol), TsNHOTBS (915 mg, 3.15 mmol), PPh3
(1.58 g, 6 mmol) and THF (3 mL) in toluene (9 mL) was added a
solution of DEAD (784 mg, 4.5 mmol) in toluene (3 mL) at 0 °C
under N2. One hour later, the solvent was removed to give a residue,
which was purified by chromatography (silica gel, 10% EtOAc in
20
PE) to give 1.33 g (98%) of product 12a as a colorless oil, [R]D
=
þ21.0 (c 0.2, CHCl3).IR:v2932, 2856, 1465 cm-1. 1HNMR:δ7.73
(d, J = 8.2, 2H), 7.33 (d, J = 7.9, 2H), 5.71-5.62 (m, 1H), 5.12-
4.98 (m, 2H), 3.02-2.83 (m, 3H), 2.71-2.51 (m, 2H), 2.44 (s, 3H),
2.16-2.06 (m, 1H), 1.97-1.91 (m, 1H), 1.74-1.23 (m, 8H), 0.93 (s,
9H), 0.30 (s, 6H). 13CNMR:δ144.3, 141.8, 129.9, 129.7 (2C), 129.1
(2C), 115.3, 66.4, 54.3, 52.4, 51.9, 33.5, 25.9 (3C), 25.8, 23.7, 23.5,
21.5, 18.0. -4.4 (2C). MS m/z (%): 452 (Mþ, 1.08), 44 (100). Anal.
calcd for C23H40N2O3SSi: C, 61.02; H, 8.91; N, 6.19. Found: C,
61.25; H, 8.99; N, 6.06.
(1S,9aR)-Octahydro-1-hydroxymethyl-spiro[1,3-dithiolane-2,
20-[2H]quinolizine] (16). To a solution of compound 15 (293 mg,
1.60 mmol) in dry CH2Cl2 was added a mixture of ethane-1,2-
dithiol (1.23 mL, 14.7 mmol) in BF3 Et2O (0.46 mL, 3.68 mmol).
3
Two hours later, the reaction was quenched by aqueous NaOH
(2.0 M, 3 mL). The resultant mixture was extracted by CH2Cl2 (3 ꢀ
20 mL) and combined organic layers were washed with H2O
(20 mL) and brine (20 mL) and dried over Na2SO4. Removal of
the solvent gave a residue, which was purified by chromatography
(silica gel, EtOAc) to give 344 mg (83%) of product 16 as a white
By similar procedure, 3-aminopropanols 11b-11k were con-
verted into the corresponding 4-methyl-benzenesulfonamides
12b-12k (see Supporting Information).
Preparation of (R)-2-Vinyl-1-piperidinepropanal Oxime (13a),
a Typical Procedure of Oximation. A stirred mixture of com-
pound 12a (453 mg, 1.0 mmol) and CsF (301 mg, 2 mmol) in
MeCN (10 mL) was heated at 60 °C under N2 for 2 h. After it was
cooled to room temperature, saturated aqueous NH4Cl was added
to quench the reaction. The resultant mixture was extracted by
EtOAc (3 ꢀ 30 mL) and combined organic layers were washed with
brine (20 mL) and dried over Na2SO4. Removal of the solvent gave
a residue, which was purified by chromatography (silica gel, 30%
EtOAc in PE) to give 171 mg (94%, E:Z=72:28) ofproduct13a as
a white crystal. It had mp 43-45 °C (PE/EtOAc), [R]D20 = þ11.2
20
solid. It had mp 128-130 °C (EtOAc), [R]D = -13.0 (c 0.1,
CHCl3). IR: v 3452, 1641, 1048, 1025 cm-1. 1H NMR: δ 4.21-4.17
(m, 1H), 3.90-3.86 (m, 1H), 3.39-3.23 (m, 4H), 2.94-2.77 (m,
3H), 2.47-2.24 (m, 2H), 2.16-1.95 (m, 4H), 1.82-1.73 (m, 2H),
1.65-1.52 (m, 2H), 1.38-1.14 (m, 2H). 13C NMR: δ 71.8, 63.7,
61.3, 56.3, 55.2, 52.7, 44.9, 39.3, 38.7, 29.9, 25.3, 24.2. MS m/z (%):
259 (Mþ, 28.33), 97 (100). Anal. calcd for C12H21NOS2: C, 55.56;
H, 8.16; N, 5.40. Found: C, 55.51; H, 8.17; N, 5.44.
(c 0.2, CHCl3). IR:v 3305, 3179, 3073, 2931, 2854, 2789, 2726 cm-1
.
Preparation of (þ)-Epilupinine (2). A suspension of compound 16
(260 mg, 1.00 mmol), Raney nickel (secondary grad, 900 mg, 15.3
mmol) in anhydrous EtOH (20 mL) was refluxed for 1.5 h. After the
reaction was cooled to room temperature, the catalyst was filtrated
off. Removal of the solvent gave a residue, which was purified by
1H NMR (as a mixture of E:Z isomers): δ 11.06 (s, br, 1H),
7.37-7.32 (m, 0.28H, minor), 6.70-6.67 (m, 0.72H, major), 5.88-
5.74 (m, 1H), 5.18-5.04 (m, 2H), 3.02-2.87 (m, 2H), 2.75-2.63
(m, 1H), 2.62-2.33 (m, 3H), 2.17-2.08 (m, 1H), 1.74-1.45 (m,
J. Org. Chem. Vol. 76, No. 1, 2011 193